Total Payments
$6,323
2024 Payments
$2,014
Companies
20
Transactions
299
Medicare Patients
4,099
Medicare Billing
$294,333
Payment Breakdown by Category
Food & Beverage$5,943 (94.0%)
Education$364.95 (5.8%)
Other$15.14 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,943 | 293 | 94.0% |
| Education | $364.95 | 5 | 5.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15.14 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,553 | 82 | $0 (2024) |
| GENZYME CORPORATION | $641.09 | 21 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $543.88 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $540.90 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $458.84 | 24 | $0 (2024) |
| UCB, Inc. | $419.03 | 28 | $0 (2024) |
| Lilly USA, LLC | $392.62 | 21 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $372.56 | 16 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $348.93 | 15 | $0 (2024) |
| LEO Pharma Inc. | $250.77 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,014 | 101 | ABBVIE INC. ($678.71) |
| 2023 | $1,798 | 73 | ABBVIE INC. ($268.80) |
| 2022 | $1,492 | 65 | ABBVIE INC. ($376.01) |
| 2021 | $1,020 | 60 | AbbVie Inc. ($229.91) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.41 | General |
| Category: Immunology | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $62.21 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Immunology | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Immunology | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Immunology | ||||||
| 10/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: DERMATOLOGY | ||||||
| 10/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,354 | 3,346 | $157,539 | $103,310 |
| 2022 | 10 | 1,209 | 2,937 | $143,600 | $93,289 |
| 2021 | 11 | 871 | 1,695 | $89,074 | $60,039 |
| 2020 | 11 | 665 | 1,165 | $72,920 | $37,695 |
Total Patients
4,099
Total Services
9,143
Medicare Billing
$294,333
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 474 | $50,373 | $31,986 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 333 | $24,984 | $17,343 | 69.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 255 | 454 | $24,905 | $14,524 | 58.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 165 | 216 | $17,777 | $11,949 | 67.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 44 | 80 | $11,028 | $7,872 | 71.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 206 | 1,571 | $8,443 | $6,070 | 71.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $8,057 | $5,337 | 66.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 53 | 61 | $5,601 | $3,938 | 70.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $4,117 | $2,574 | 62.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 40 | 55 | $2,253 | $1,715 | 76.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 274 | 479 | $51,310 | $33,700 | 65.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 216 | 386 | $21,294 | $13,081 | 61.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 190 | $14,379 | $10,084 | 70.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 54 | 89 | $12,280 | $8,646 | 70.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 123 | 147 | $12,311 | $7,916 | 64.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $11,916 | $6,945 | 58.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 180 | 1,411 | $8,269 | $5,509 | 66.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 62 | 70 | $6,456 | $4,218 | 65.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 38 | 38 | $3,575 | $1,858 | 52.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 34 | 42 | $1,811 | $1,333 | 73.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 187 | $20,220 | $14,915 | 73.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 163 | 288 | $21,935 | $14,087 | 64.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 109 | 143 | $12,058 | $7,941 | 65.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 144 | 226 | $12,226 | $6,861 | 56.1% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 47 | 53 | $4,875 | $3,657 | 75.0% |
About Jessica Hudson, NP
Jessica Hudson, NP is a Obstetrics & Gynecology healthcare provider based in Milledgeville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2010. The National Provider Identifier (NPI) number assigned to this provider is 1376854091.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Hudson, NP has received a total of $6,323 in payments from pharmaceutical and medical device companies, with $2,014 received in 2024. These payments were reported across 299 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,943).
As a Medicare-enrolled provider, Hudson has provided services to 4,099 Medicare beneficiaries, totaling 9,143 services with total Medicare billing of $294,333. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Nurse Practitioner
- Location Milledgeville, GA
- Active Since 06/28/2010
- Last Updated 12/17/2019
- Taxonomy Code 363LX0001X
- Entity Type Individual
- NPI Number 1376854091
Products in Payments
- DUPIXENT (Biological) $1,169
- SKYRIZI (Biological) $802.10
- TREMFYA (Drug) $531.87
- RINVOQ (Biological) $511.14
- TALTZ (Drug) $375.32
- Sotyktu (Drug) $258.94
- ADBRY (Biological) $250.77
- Cimzia (Drug) $241.35
- HUMIRA (Biological) $240.19
- Bimzelx (Biological) $177.68
- ILUMYA (Biological) $147.08
- OPZELURA (Drug) $144.85
- COSENTYX (Drug) $130.68
- Otezla (Drug) $105.86
- Enbrel (Biological) $101.56
- REMICADE (Biological) $100.06
- EUCRISA (Drug) $85.71
- AREXVY (Drug) $65.86
- COSENTYX (Biological) $48.99
- Seysara (Drug) $39.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Milledgeville
Jenelle Robinson, Md, MD
Obstetrics & Gynecology — Payments: $1,786
Obstetrics & Gynecology $1,786
Dr. Charles Brown, Md, MD
Obstetrics & Gynecology — Payments: $1,667
Obstetrics & Gynecology $1,667
Marisol San Inocencio, Md, MD
Obstetrics & Gynecology — Payments: $1,321
Obstetrics & Gynecology $1,321
Dr. Suzanne Palmer, Md, MD
Obstetrics & Gynecology — Payments: $1,010
Obstetrics & Gynecology $1,010